Heme/Onc – Page 5 – Clinical Correlations

Breast Self-Examination: Worth the Effort?

October 5, 2011

Class Act Heme/Onc 5 min read

By Katherine Husk

Faculty Peer Reviewed

A healthy 40-year-old woman comes into your office for a routine health exam.Â After you have performed a clinical breast exam, she asks you whether she should be examining her breasts on …

What is Sister Mary Josephâ€™s Nodule And Why Is It Significant?

September 15, 2011

Class Act Heme/Onc 4 min read

By Keri Herzog, MD
Faculty Peer Reviewed

The patient is a 62-year-old male who presented to an outpatient medical clinic complaining of a growing, slightly painful, periumbilical mass, and mild lower gastrointestinal discomfort over the last 4 months. On examination, the …

Avastin and the Meaning of Evidence

September 9, 2011

Ethics Heme/Onc Pharmacology 7 min read

By Antonella Surbone MD PhDÂ and Jerome Lowenstein MD

The recent hearings at the Food and Drug Administration regarding the revocation of approval for the use of Avastin in the treatment of breast cancer [1,2,3] bring into sharp focus several …

Should My Patient with a Solid Tumor be Anticoagulated in the Absence of Venous Thromboembolism?

September 8, 2011

Class Act Heme/Onc 6 min read

By David Altszuler, Class of 2012

Faculty Peer Reviewed

An empiric association between occult malignancy and thrombophlebitis has been recognized since Trousseau first reported the syndrome in 1865.[1]Â The mechanism by which cancer predisposes to thrombophilia has not been fully elucidated; …

Low Dose Vitamin K Supplementation and Anticoagulation Control

July 21, 2011

Heme/Onc Pharmacology 7 min read

By Joanna Becker

Faculty Peer Reviewed

Patients who are placed on long-term warfarin (Coumadin) therapy are sent home with a lengthy list of restrictions to minimize variations in warfarin efficacy. The agents that can alter warfarin levels can be divided …